Aargauer Zeitung dedicates an article to Fabia Gozzo

19th December 2019

Presentation of ESS Case studies at the joint CCG/IG Autumn Meeting

20th November 2019

The joint CCG/IG autumn meeting "By hook or by crook - structural solutions from challenging crystals" was held at GSK site in Stevenage on the 20th November 2019. On this occasion, Mathilde Reinle-Schmitt presented results collected in the frame of ESS Case Studies program, launched for the joint SPS-XRPD-2/PPXRD-16 conference in May 2019. The talk was entitled 'Beyond the limits of conventional techniques: subtle structural differences influencing solubility unveiled by synchrotron-XRPD' and described how the use of S-XRPD could solve issues in industrial pharmaceutical R&D.

Video available for the 7th Webinar of ACCELERATE, a Horizon2020 project dedicated to the support of large research infrastructures

6th November 2019

In the ACCELERATE Webinar #7 "The development of Synchrotron-XRPD analytical services to best meet the needs of the pharmaceutical industry", that took place on November 6th, 2019, Dr. Fabia Gozzo, founder of Excelsus Structural Solutions discussed the key role that these tools can play throughout the whole lifecycle of pharmaceuticals, from development to commercial production, including in the field of IP protection.

Among other topics, she presented Excelsus Structural Solutions' business model, developed to make complex Synchrotron-XRPD techniques readily available to the pharmaceutical industry for both "routine" measurements and investigational studies. More information can be found on the following link:


Link to more info


The video of the ACCELERATE Webinar #7 "The development of Synchrotron-XRPD analytical services to best meet the needs of the pharmaceutical industry is from now on available on the following link:


Link to video

Interview of Fabia Gozzo in Dectris Newsletter

5th November 2019

Excelsus'CEO, Fabia Gozzo has been recently interviewed for the newsletter of Dectris. In this article, she answered practical questions about the use of synchrotron radiation for industrial pharmaceutical R&D and highlighted several examples in which synchrotron X-Ray Powder Diffraction was used to solve issues related to drug development. The article can be found on the following link:


Link to the article



Excelsus is opening a new job position
10th September 2019

Title: Technician for Synchrotron-radiation X-ray powder analysis


If you are interested in working for a growing scientific/technological company, then send us your application in English at together with a strong motivation letter. Or contact us if you have any questions!


Click here for the full job description.

Fabia Gozzo, founder of Excelsus, nominated for GWIIN award
13th June 2019

The Global Women Inventors and Innovators Network (GWIIN), a non-profit organization, was founded to celebrate this women's creativity and entrepreneurship and to increase their success rate. Every year it awards women for their inventions of all type – science, high- and low-tech, design, arts, education, food.

This year, Fabia Gozzo, founder of Excelsus Structural Solutions, a spin-off of the PSI, and pioneer of the industrial use of Synchrotron X-Ray Powder Diffraction for the study of pharmaceuticals is among the nominees for the award in the category "Exceptional Creative, Inventive or Innovative Women in Micro-enterprise or New Start-up business".

Fabia will present her company at the GWIIN Exhibition on June 27-28 in London.


A platform to discuss high-level topics with the pharmaceutical industry
23rd May 2019

From May 9 to 12, 2019, the Second Annual Spring Pharmaceutical Synchrotron X-Ray Powder Diffraction (SPS-XRPD-2) Workshop took place at the Paul Scherrer Institute PSI in Villigen, Switzerland. Jointly organized with the 16th Pharmaceutical Powder X-Ray Diffraction Symposium (PPXRD-16) by the International Centre for Diffraction Data (ICDD), the SPS-XRPD-2 meeting followed a successful first edition last year at Purdue University. Supporting the conference, Excelsus Structural Solutions (Swiss) AG in cooperation with the Swiss Light Source (SLS) Materials Science launched a complementary case study program, allowing the pharmaceutical industry to explore the possibilities offered by synchrotron X-ray powder diffraction, free of charge.



Interview of Fabia Gozzo on the Ticino's Swiss television RSI
22nd February 2019

An interesting reportage broadcast on Ticino's Swiss television on the developments of the five Swiss scientific Parks (Lausanne, Bienne, Basel, Aarau and Zurich) united in a consortium under the Switzerland Innovation Foundation and plans of Ticino to join. Created in 2016, the mission of Switzerland Innovation is to join forces around the common goals of strengthening the connections between academia and industry. PARK INNOVAARE is referred as a successful example of an organization fostering young high-technological spin-off companies and helping them growing up. Interview to Excelsus Structural Solutions.

Fabia Gozzo, Excelsus' CEO at the 9th HECRA meeting
8th October 2018

Fabia Gozzo, CEO of Excelsus Structural Solutions (ESS), has given a keynote lecture at the 9th Hellenic Crystallographic Association meeting (HECRA) on October 7th, 2018 at the University of Patras in Greece. In her talk 'Harnessing the synchrotron radiation technology to meet the needs of the Pharma industry', she described the challenges faced as well as the solutions brought by ESS team to make accessible advanced Synchrotron X-Ray Powder Diffraction analysis to Pharmaceutical Companies in order to solve issues related to the drug development cycle.

Joint meeting: PPXRD-16 and SPS-XRPD-2
5th October 2018

Excelsus Structural Solutions has the pleasure to announce that the next edition of the SPS-XRPD workshop will be held together with the PPXRD-16 symposium in May 2019 in Switzerland!

Read more>

 1  2  3 
Privacy    Cookie Policy
realizzazione siti web